IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 242 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,547,000 | +8.0% | 520,000 | 0.0% | 0.77% | +15.2% |
| Q4 2021 | $6,063,000 | -10.7% | 520,000 | 0.0% | 0.67% | -14.5% |
| Q3 2021 | $6,791,000 | +1.5% | 520,000 | 0.0% | 0.78% | +6.8% |
| Q2 2021 | $6,692,000 | +15.1% | 520,000 | 0.0% | 0.74% | +5.5% |
| Q1 2021 | $5,814,000 | +1.7% | 520,000 | +3.6% | 0.70% | -20.9% |
| Q4 2020 | $5,716,000 | +26.6% | 501,874 | 0.0% | 0.88% | +7.6% |
| Q3 2020 | $4,514,000 | +6.8% | 501,874 | +22.6% | 0.82% | +6.1% |
| Q2 2020 | $4,226,000 | +946.0% | 409,500 | +923.8% | 0.77% | +841.5% |
| Q1 2020 | $404,000 | +344.0% | 40,000 | +378.6% | 0.08% | +583.3% |
| Q2 2019 | $91,000 | – | 8,358 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
| 13D Management LLC | 600,431 | $6,923,000 | 3.06% |
| BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
| Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
| Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
| Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
| ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
| Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
| CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |